DFDS’ EBIT outlook range for 2024 has been lowered following a Q2 2024 result below expectations. The level of freight activity in the rest of the year is moreover expected to be below previous expectations.
Posted: 2024-07-22 07:02:00
Globe NewsWire News Distribution Service
Press Release: DFDS LOWERS EBIT 2024 OUTLOOK RANGE BUT MAINTAINS CASH FLOW OUTLOOK
- Details
- Written by Globe NewsWire Press Releases
- Category: Globe NewsWire News Distribution Service
DFDS’ EBIT outlook range for 2024 has been lowered following a Q2 2024 result below expectations. The level of freight activity in the rest of the year is moreover expected to be below previous expectations.
Posted: 2024-07-22 07:02:00
Listen to this article. Speaker link opens in a new window.
Related News Stories From The Web And More
Related Bing News Search Results
Press Release: DFDS LOWERS EBIT 2024 OUTLOOK RANGE BUT MAINTAINS CASH FLOW OUTLOOK - Newscast
Advancing the Power of Facts
Fri, 20 Sep 2024 02:48:00 GMT By ELLEN KNICKMEYER, The Associated Press WASHINGTON (AP) — Seven news organizations filed a legal motion Friday asking the U.S. military commission at Guantanamo Bay, Cuba, to make public the plea ...Scotiabank lowers outlook for BioMarin shares, highlights competitive risks to Voxzogo franchise
Tue, 17 Sep 2024 07:04:00 GMT On Tuesday, Scotiabank adjusted its outlook on BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), reducing the price target to $78 from the previous $95, while maintaining a Sector Perform rating for the ...Scotiabank lowers outlook for BioMarin shares, highlights competitive risks to Voxzogo franchise
Tue, 17 Sep 2024 06:07:00 GMT On Tuesday, Scotiabank adjusted its outlook on BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), reducing the price target to $78 from the previous $95, while maintaining a Sector Perform rating for the ...Outlook Therapeutics® to Participate in the Virtual Investor Closing Bell Series
Mon, 16 Sep 2024 05:06:00 GMT Live video webcast with Russell Trenary, President and CEO of Outlook Therapeutics on Thursday, September 19th at 4:00 PM ET ISELIN, N.J., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc.ECB Slightly Lowers Growth Outlook For 2024-2026
Wed, 11 Sep 2024 16:59:00 GMT The European Central Bank on Thursday slightly lowered its growth expectations for the entire length of the forecast, while leaving inflation projections unchanged. The eurozone economy is ...
